FDA Commissioner With Industry Background Would Be “Strong Plus” – Hatch
Executive Summary
Industry experience should be considered an advantage for potential commissioner candidates in light of the importance of bioterrorism preparedness, Sen. Orrin Hatch (R-Utah) maintained April 16 at the Food & Drug Law Institute meeting in Washington, D.C
You may also be interested in...
FDA Management Hierarchy Under Crawford Takes Shape; Alderson Elevated
The appointment of Center for Veterinary Medicine Office of Research Director Norris Alderson, PhD, as senior associate commissioner for science indicates that acting Commissioner Lester Crawford, PhD, is preparing for a prolonged tenure as head of FDA
FDA Animal Efficacy Rule Needs To Be Codified In Bioterror Bill – Hatch
Sen. Orrin Hatch (R-Utah) is pushing for changes to the bioterrorism conference bill that would codify FDA's animal efficacy rule, he told a Food & Drug Law Institute meeting in Washington, D.C., April 15
FDA Animal Efficacy Rule Needs To Be Codified In Bioterror Bill – Hatch
Sen. Orrin Hatch (R-Utah) is pushing for changes to the bioterrorism conference bill that would codify FDA's animal efficacy rule, he told a Food & Drug Law Institute meeting in Washington, D.C., April 15